Card image cap

Elizabeth Warren's Public Statements on Issue: Drugs

Office:
6

Current Issue:

Drugs

Speech Type

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 6
Date Title
02/07/2024 Warren, Doggett, King, 75 Lawmakers Urge Biden Administration to Lower Prescription Drug Prices
01/30/2024 Warren, Fetterman, Schumer, Senators Urge Biden Administration to Swiftly Deschedule Marijuana
01/11/2024 At Hearing, Warren, DEA Official Confirm Crypto's Role in Fueling Illegal Fentanyl Trade
12/14/2023 In Newsweek Op-ed, Senator Warren Praises President Biden's Action to Lower Drug Costs, Urges Americans to Fight Back Against Big Pharma's Unreasonable Drug Prices
12/14/2023 Warren, Jayapal Blast Big Pharma's Sham Patent Claims, Urge Companies to End Abusive Patent Practices that Cost Patients Billions
11/15/2023 Warren, Merkley, Warnock, Blumenauer, 16 Lawmakers Push For New Marijuana Banking Guidance for Fairer Access to Financial Services for Legal Marijuana Businesses
06/21/2023 At Banking Committee Markup, Warren Supports Bill to Hold Failed Bank Executives Accountable
05/31/2023 At Hearing, Warren Calls for Closing Crypto Loopholes Fueling Fentanyl Trade
05/11/2023 At Hearing, Senator Warren Calls for Federal Legalization of Marijuana, Highlights Need for Passage of the SAFE Banking Act
01/11/2023 Senators Warren, King and Representative Doggett Urge HHS to Use Its Authority to Lower the Price of Cancer Treatment Drug Xtandi
09/28/2022 Letter to Lloyd Austin, Secretary of Defense - Senator Markey Raises Alarm on Fatal Overdoses Among Active Duty Service Members
07/25/2022 Letter to Hon. Robert M. Califf, Commissioner of the FDA - Senator Baldwin Voices Support for FDA's Proposed "Life-Saving" Ban on Menthol Cigarettes and Flavored Cigars
05/20/2022 Letter to Robert M. Califf, MD, Commissioner of the US Food and Drug Administration - Senator Baldwin, Democratic Colleagues To FDA Commissioner: Remove All Unauthorized E-Cigarettes From Market Immediately
04/25/2022 Warren Urges Biden Administration to Lower Prescription Drug Prices Using Existing Executive Authority
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/16/2022 Schakowsky, Warren, Klobuchar, Porter, Colleagues Call Out Drug Manufacturers For Providing Misleading Information on High Drug Prices
03/10/2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
03/01/2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
02/16/2022 Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC
12/21/2021 Van Hollen, Warren, Baldwin, Maloney Reintroduce Landmark CARE Act to Combat the Substance Use Epidemic
12/16/2021 Baldwin, Warren, Maloney Lead More than 100 Democrats in Senate and House in Reintroducing Landmark CARE Act to Combat the Substance Use Epidemic
11/10/2021 Letter to Hon. Joseph R. Biden, President of the United States - Markey, Warren, and Merkley Urge Biden to Issue Blanket Cannabis Pardons
11/04/2021 Rubio, Warren Introduce Bill to Address U.S. Overreliance on Foreign Pharmaceuticals
08/23/2021 Letter to Janet Woodcock, Acting Commissioner of Food and Drug Administration - Senators Hassan, Grassley, and Whitehouse Lead Call to FDA to Provide Answers on Potential Conflicts of Interest with Consulting Firm McKinsey in Relation to Opioid Crisis
08/06/2021 Letter to the Honorable Merrick Garland, Attorney General - Warren, Blumenthal, Maloney, and DeSaulnier Urge DOJ to Immediately Appeal Purdue Pharma's Bankruptcy Plan that Would Shield Sackler Family from Accountability for Opioid Crisis
Page 1 of 6
arrow_upward